Literature DB >> 31201495

Is There an Optimal Time for Parathyroidectomy in Patients with Secondary Hyperparathyroidism?

Tracy S Wang1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31201495     DOI： 10.1007/s00268-019-05063-2

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  5 in total

Review 1.  Surgical management of secondary hyperparathyroidism in chronic kidney disease--a consensus report of the European Society of Endocrine Surgeons.

Authors:  Kerstin Lorenz; Detlef K Bartsch; Juan J Sancho; Sebastien Guigard; Frederic Triponez
Journal:  Langenbecks Arch Surg       Date:  2015-10-02       Impact factor: 3.445

2.  Timing of Parathyroidectomy Does Not Influence Renal Function After Kidney Transplantation.

Authors:  Willemijn Y van der Plas; Mostafa El Moumni; Philipp J von Forstner; Ezra Y Koh; Roderick R Dulfer; Tessa M van Ginhoven; Joris I Rotmans; Natasha M Appelman-Dijkstra; Abbey Schepers; Ewout J Hoorn; John Th M Plukker; Liffert Vogt; Anton F Engelsman; Els J M Nieveen van Dijkum; Schelto Kruijff; Robert A Pol; Martin H de Borst
Journal:  World J Surg       Date:  2019-08       Impact factor: 3.352

3.  Cardiovascular and Cerebrovascular Events After Parathyroidectomy in Patients on Renal Replacement Therapy.

Authors:  Kerstin M Ivarsson; Shahriar Akaberi; Elin Isaksson; Eva Reihnér; Tomasz Czuba; Karl-Göran Prütz; Naomi Clyne; Martin Almquist
Journal:  World J Surg       Date:  2019-08       Impact factor: 3.352

4.  Parathyroidectomy prior to kidney transplant decreases graft failure.

Authors:  Glenda G Callender; Jennifer Malinowski; Mahsa Javid; Yawei Zhang; Huang Huang; Courtney E Quinn; Tobias Carling; Ricarda Tomlin; J Douglas Smith; Sanjay Kulkarni
Journal:  Surgery       Date:  2016-11-15       Impact factor: 3.982

Review 5.  Secondary Hyperparthyroidism: Pathogenesis, Diagnosis, Preventive and Therapeutic Strategies.

Authors:  Mariano Rodríguez Portillo; María E Rodríguez-Ortiz
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.